Newmont Investing Cash Flow decreased by 144.5% to -$302.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 140.9%, from $738.00M to -$302.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows a downward trend with a 13.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$777.00M | -$390.00M | -$351.00M | -$519.00M | -$515.00M | -$1.22B | -$726.00M | -$342.00M | -$158.00M | -$253.00M | -$249.00M | -$798.00M | -$641.00M | -$562.00M | -$701.00M | $738.00M | $679.00M | -$302.00M |
| QoQ Change | — | +49.8% | +10.0% | -47.9% | +0.8% | -137.5% | +40.6% | +52.9% | +53.8% | -60.1% | +1.6% | -220.5% | +19.7% | +12.3% | -24.7% | +205.3% | -8.0% | -144.5% |
| YoY Change | — | — | — | — | +33.7% | -213.6% | -106.8% | +34.1% | +69.3% | +79.3% | +65.7% | -133.3% | -305.7% | -122.1% | -181.5% | +192.5% | +205.9% | -140.9% |